Skip to content

US · HNGE · MEDICAL - HEALTHCARE INFORMATION SERVICES

Hinge Health, Inc. (HNGE) intrinsic value and stock valuation

$105.78as of 2026-11-21 · Mkt cap 6.25B

Data updated · price as of 2026-11-21

Strongly overvaluedIC value is more than 50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Hinge Health, Inc. DCF and intrinsic value

InvestorsCraft values HNGE with the Chepakovich two-stage DCF model — currently rated strongly overvalued. How the model works · Run your own DCF prefilled from HNGE’s statements →

Hinge Health, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Healthcare Information Services San Francisco, CA 94105 hingehealth.com

How the business is doing

Fiscal 2023–2025, USD

Revenue
$587.9M
20232025
Net income
-$-528.26M
20232025
Free cash flow
$170.7M
20232025
Total equity
$378.5M
20232025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2023–2025, USD
202520242023
Revenue$587.9M$390.4M$292.7M
Operating income-$-546.37M-$-31.91M-$-130.51M
Net income-$-528.26M-$-11.93M-$-108.14M
EPSd-$-6.47M-$-152.91K-$-1.39M
Operating cash flow$171.4M$49M-$-63.91M
Capital expenditure-$-710K-$-3.77M-$-4.62M
Free cash flow$170.7M$45.2M-$-68.52M
Total assets$744.8M$673.3M$622.5M
Total debt$8.04M$11.1M$15.7M
Net debt-$-199.96M-$-289.71M-$-219.22M
Total equity$378.5M$416.7M$427.3M
Cash and short-term investments$363.9M$466.6M$423.4M
Income statement
202520242023
Revenue$587.9M$390.4M$292.7M
Cost of revenue$118.6M$89.8M$98.6M
Gross profit$469.3M$300.6M$194.2M
Research and development expenses$368.1M$100.8M$110.1M
Selling, general and administrative expenses$639.4M$227.5M$214.6M
Other expenses$8.12M$4.13M$0.00
Operating expenses$1.02B$332.5M$324.7M
Cost and expenses$1.13B$422.3M$423.2M
Interest income$0.00$0.00$0.00
Interest expense$0.00$0.00$0.00
Depreciation and amortization$5.13M$2.35M$2.13M
Ebitda-$-535.89M-$-22.08M-$-128.39M
Operating income-$-546.37M-$-31.91M-$-130.51M
Total other income/expenses, net$19.1M$20.7M$22M
Income before tax-$-527.26M-$-11.26M-$-108.55M
Income tax expense$1M$680K-$-410K
Net income-$-528.26M-$-11.93M-$-108.14M
Weighted average shares outstanding$79.2M$78M$78M
Weighted average diluted shares outstanding$81.7M$78M$78M
Balance sheet
202520242023
Cash and short-term investments$363.9M$466.6M$423.4M
Net receivables$66.1M$42.5M$46.6M
Inventory$15.6M$10.9M$13.3M
Total current assets$533.9M$583.5M$529.9M
Property, plant and equipment, net$17.4M$17M$22.5M
Goodwill and intangible assets$66.6M$63.4M$63.8M
Long-term investments$113.2M$0.00$0.00
Total non-current assets$210.9M$89.8M$92.7M
Total assets$744.8M$673.3M$622.5M
Accounts payable$0.00$0.00$0.00
Short-term debt$4.22M$3.81M$4.64M
Deferred revenue$300.9M$217.6M$140.5M
Total current liabilities$362.4M$249.3M$184.2M
Long-term debt$3.82M$7.26M$11.1M
Deferred revenue, non-current$0.00$0.00$0.00
Total non-current liabilities$3.82M$7.26M$11.1M
Capital lease obligations$8.04M$11.1M$15.7M
Total liabilities$366.2M$256.6M$195.3M
Common stock$0.00$0.00$0.00
Retained earnings-$-1.05B-$-522.74M-$-510.8M
Accumulated other comprehensive income (loss)-$-20K$70K$60K
Total equity$378.5M$416.7M$427.3M
Total investments$269M$165.8M$188.4M
Total debt$8.04M$11.1M$15.7M
Net debt-$-199.96M-$-289.71M-$-219.22M
Cash flow statement
202520242023
Net income-$-528.26M-$-11.93M-$-108.14M
Depreciation and amortization$5.49M$5.95M$5.63M
Stock-based compensation$643M$740K$1.65M
Change in working capital-$-2.01M$13.5M$9.41M
Accounts receivable-$-26.63M-$-1.34M-$-23.13M
Inventory-$-4.76M$610K$10.6M
Accounts payable$29.4M-$-10.97M$0.00
Net cash provided by operating activities$171.4M$49M-$-63.91M
Investments in property, plant and equipment-$-710K-$-1.04M-$-1.98M
Acquisitions, net-$-4M$0.00$0.00
Net cash used for investing activities-$-113.76M$18.3M$1.5M
Common stock issued$265.2M$610K$0.00
Common stock repurchased-$-65.03M$0.00$0.00
Dividends paid$0.00$0.00$0.00
Net cash used for financing activities-$-150.47M-$-2.2M-$-3M
Net change in cash-$-92.79M$65.1M-$-65.41M
Cash at end of period$209.8M$302.6M$237.5M
Operating cash flow$171.4M$49M-$-63.91M
Capital expenditure-$-710K-$-3.77M-$-4.62M
Free cash flow$170.7M$45.2M-$-68.52M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Hinge Health, Inc.

        Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.

        CEO
        Daniel A. Perez
        Employees
        1.44K
        Beta
        1.27

        Explore

        Frequently asked questions

        What is the intrinsic value of Hinge Health, Inc. (HNGE)?

        Hinge Health, Inc. (HNGE) is currently strongly overvalued based on the InvestorsCraft IC model — IC value is more than 50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is HNGE undervalued?

        HNGE trades at a price of $105.78 (Nov 21, 2026): strongly overvalued — IC value is more than 50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.